Leukotriene D4 [leukotrien D4]
topical
3
- Terms
-
Leukotriene D
Leukotriene D-4
Leukotrienes D
LTD4
Persistent link
https://www.medvik.cz/link/D017998
Definition
One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)
- DUI
- D017998 MeSH Browser
- CUI
- M0027179
- CAS
- Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))-
- Previous indexing
- SRS-A (1982-1993)
- History note
- 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
- Online note
- use SRS-A to search LEUKOTRIENE D4 & LEUKOTRIENES D 1983-93
- Public note
- 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis 2
- AI
- antagonists & inhibitors 1
- BI
- biosynthesis
- BL
- blood 1
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine 1
...
Occurrences in Medvik records
D
Chemicals and Drugs